Telix Pharmaceuticals Limited is seeking a seasoned CMC Program Lead to oversee antibody-based radiopharmaceutical programs TLX597 & TLX66. You will drive CMC strategy across preclinical through phase 3, coordinating internal sites and external partners with a robust emphasis on QbD, risk management, and Stage-Gate readiness. You will manage a cross-functional team, ensure timely deliverables, and communicate with senior management regarding timelines and resource needs.